William R. Jarnagin, MD, FACS

William R. Jarnagin, MD, FACS

William R. Jarnagin, MD, FACS

Profile:

Dr. Jarnagin is Chief Attending Surgeon in the Hepatopancreatobiliary Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center. He holds the Benno C. Schmidt Chair in Surgery. Dr. Jarnagin has expressed a keen interest in research and has been actively involved in clinical trials since 1997. Dr. Jarnagin is actively investigating cutting-edge therapies for patients with bile duct cancer and primary liver cancer which cannot be treated surgically. By working with medical oncology and radiology, he studies the tumor’s response of this treatment. Doing this greatly helps Dr. Jarnagin’s understanding of the tumor and how it develops.

Meet Dr. Jarnagin:


Publications:

  1. Zheng, J, Chapman, WC, Turcotte, S, Koerkamp, BG, Lee, SY, Jarnagin, WR et al.. Response to the Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort". Ann. Surg. 2019;269 (3):e34-e35. doi: 10.1097/SLA.0000000000002871. PubMed PMID:30724808 .
  2. Narayan, RR, Goldman, DA, Gonen, M, Reichel, J, Huberman, KH, Raj, S et al.. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. Ann. Surg. Oncol. 2019; :. doi: 10.1245/s10434-019-07201-5. PubMed PMID:30706231 .
  3. Pak, LM, Gagnière, J, Allen, PJ, Balachandran, VP, D'Angelica, MI, DeMatteo, RP et al.. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases. J. Gastrointest. Surg. 2019; :. doi: 10.1007/s11605-019-04106-2. PubMed PMID:30680630 .
  4. Lawrence, SA, McIntyre, CA, Pulvirenti, A, Seier, K, Chou, Y, Gonen, M et al.. Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. J. Am. Coll. Surg. 2019; :. doi: 10.1016/j.jamcollsurg.2018.12.018. PubMed PMID:30630087 .
  5. Wong, W, Lowery, MA, Berger, MF, Kemel, Y, Taylor, B, Zehir, A et al.. Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes. Cancer. 2019; :. doi: 10.1002/cncr.31951. PubMed PMID:30620386 .
  6. Speers, AD, Ma, B, Jarnagin, WR, Himidan, S, Simpson, AL, Wildes, RP et al.. Fast and accurate vision-based stereo reconstruction and motion estimation for image-guided liver surgery. Healthc Technol Lett. 2018;5 (5):208-214. doi: 10.1049/htl.2018.5071. PubMed PMID:30464852 PubMed Central PMC6222177.
  7. Narayan, RR, Creasy, JM, Goldman, DA, Gönen, M, Kandoth, C, Kundra, R et al.. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations. Cancer. 2019;125 (4):575-585. doi: 10.1002/cncr.31850. PubMed PMID:30427539 .
  8. Lee, SY, Goh, BKP, Sepideh, G, Allen, JC, Merkow, RP, Teo, JY et al.. Laparoscopic Liver Resection Difficulty Score-a Validation Study. J. Gastrointest. Surg. 2018; :. doi: 10.1007/s11605-018-4036-y. PubMed PMID:30421119 .
  9. Kunstman, JW, Goldman, DA, Gönen, M, Balachandran, VP, D'Angelica, MI, Kingham, TP et al.. Outcomes after Pancreatectomy with Routine Pasireotide Use. J. Am. Coll. Surg. 2019;228 (2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. PubMed PMID:30414453 .
  10. Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP et al.. Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients. World J Surg. 2019;43 (2):395. doi: 10.1007/s00268-018-4845-x. PubMed PMID:30406321 .
  11. Al Efishat, M, Attiyeh, MA, Eaton, AA, Gönen, M, Covey, AM, D'Angelica, MI et al.. Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. HPB (Oxford). 2018; :. doi: 10.1016/j.hpb.2018.08.010. PubMed PMID:30293867 .
  12. Gaspersz, MP, Buettner, S, Roos, E, van Vugt, JLA, Coelen, RJS, Vugts, J et al.. A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma. J Surg Oncol. 2018;118 (3):469-476. doi: 10.1002/jso.25174. PubMed PMID:30132904 .
  13. Attiyeh, MA, Chakraborty, J, Gazit, L, Langdon-Embry, L, Gonen, M, Balachandran, VP et al.. Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. HPB (Oxford). 2018; :. doi: 10.1016/j.hpb.2018.07.016. PubMed PMID:30097414 PubMed Central PMC6367060.
  14. Olthof, PB, Miyasaka, M, Koerkamp, BG, Wiggers, JK, Jarnagin, WR, Noji, T et al.. A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers. HPB (Oxford). 2018; :. doi: 10.1016/j.hpb.2018.07.014. PubMed PMID:30087051 .
  15. Tufts, LS, Jarnagin, ED, Flynn, JR, Gonen, M, Guillem, JG, Paty, PB et al.. A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. HPB (Oxford). 2018; :. doi: 10.1016/j.hpb.2018.07.001. PubMed PMID:30077525 PubMed Central PMC6358518.
  16. Zheng, J, Sadot, E, Vigidal, JA, Klimstra, DS, Balachandran, VP, Kingham, TP et al.. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS ONE. 2018;13 (7):e0200776. doi: 10.1371/journal.pone.0200776. PubMed PMID:30052636 PubMed Central PMC6063411.
  17. Lidsky, ME, Jarnagin, WR. Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center. Ann Gastroenterol Surg. 2018;2 (4):304-312. doi: 10.1002/ags3.12181. PubMed PMID:30003193 PubMed Central PMC6036362.
  18. Gagnière, J, Dupré, A, Gholami, SS, Pezet, D, Boerner, T, Gönen, M et al.. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. Ann. Surg. 2018; :. doi: 10.1097/SLA.0000000000002968. PubMed PMID:29995686 .
  19. Zheng, J, Chapman, WC, Turcotte, S, Koerkamp, BG, Lee, SY, Jarnagin, WR et al.. "Response to Letter to the Editor: Impact of Recurrence Surveillance on Recurrence Patterns After Resection of Hepatocellular Carcinoma". Ann. Surg. 2018; :. doi: 10.1097/SLA.0000000000002871. PubMed PMID:29958228 .
  20. Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP et al.. Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients. World J Surg. 2019;43 (2):385-394. doi: 10.1007/s00268-018-4726-3. PubMed PMID:29955938 PubMed Central PMC6310662.
Search PubMed